1 month Starboard Slams Pfizer for R&D Inefficiencies, Overpaid AcquisitionsZacks
Starboard calls out PFE’s board of directors to take action against the latter’s management for not earning sustainable revenue returns on R&D and M&A.
New York · Pfizer (PFE) · Science · U.S. · York
X